4-[(2S,3R,5S)-5-(4-hydroxyphenyl)-3-methyl-4-methylideneoxolan-2-yl]phenol

Details

Top
Internal ID 0823928e-7f94-4f1e-a688-95406f5be34c
Taxonomy Benzenoids > Phenols > 1-hydroxy-2-unsubstituted benzenoids
IUPAC Name 4-[(2S,3R,5S)-5-(4-hydroxyphenyl)-3-methyl-4-methylideneoxolan-2-yl]phenol
SMILES (Canonical) CC1C(OC(C1=C)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O
SMILES (Isomeric) C[C@H]1[C@H](O[C@@H](C1=C)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O
InChI InChI=1S/C18H18O3/c1-11-12(2)18(14-5-9-16(20)10-6-14)21-17(11)13-3-7-15(19)8-4-13/h3-10,12,17-20H,1H2,2H3/t12-,17+,18+/m1/s1
InChI Key GUFYIKUMMMQMOP-UUWFMWQGSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C18H18O3
Molecular Weight 282.30 g/mol
Exact Mass 282.125594432 g/mol
Topological Polar Surface Area (TPSA) 49.70 Ų
XlogP 3.20
Atomic LogP (AlogP) 4.10
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 4-[(2S,3R,5S)-5-(4-hydroxyphenyl)-3-methyl-4-methylideneoxolan-2-yl]phenol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9956 99.56%
Caco-2 + 0.6082 60.82%
Blood Brain Barrier - 0.7000 70.00%
Human oral bioavailability - 0.6857 68.57%
Subcellular localzation Mitochondria 0.7575 75.75%
OATP2B1 inhibitior - 0.8543 85.43%
OATP1B1 inhibitior + 0.7208 72.08%
OATP1B3 inhibitior + 0.9149 91.49%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.8800 88.00%
P-glycoprotein inhibitior - 0.7826 78.26%
P-glycoprotein substrate - 0.9319 93.19%
CYP3A4 substrate - 0.5499 54.99%
CYP2C9 substrate - 0.7433 74.33%
CYP2D6 substrate - 0.7074 70.74%
CYP3A4 inhibition + 0.6650 66.50%
CYP2C9 inhibition + 0.8303 83.03%
CYP2C19 inhibition + 0.8485 84.85%
CYP2D6 inhibition - 0.9251 92.51%
CYP1A2 inhibition + 0.8263 82.63%
CYP2C8 inhibition - 0.6330 63.30%
CYP inhibitory promiscuity + 0.9833 98.33%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.8235 82.35%
Carcinogenicity (trinary) Danger 0.5116 51.16%
Eye corrosion - 0.9832 98.32%
Eye irritation + 0.6270 62.70%
Skin irritation - 0.7200 72.00%
Skin corrosion - 0.8850 88.50%
Ames mutagenesis - 0.5400 54.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7426 74.26%
Micronuclear + 0.7200 72.00%
Hepatotoxicity + 0.5125 51.25%
skin sensitisation - 0.5288 52.88%
Respiratory toxicity - 0.7556 75.56%
Reproductive toxicity + 0.6444 64.44%
Mitochondrial toxicity - 0.6125 61.25%
Nephrotoxicity + 0.6356 63.56%
Acute Oral Toxicity (c) III 0.7594 75.94%
Estrogen receptor binding + 0.6320 63.20%
Androgen receptor binding + 0.8202 82.02%
Thyroid receptor binding + 0.6837 68.37%
Glucocorticoid receptor binding + 0.5500 55.00%
Aromatase binding + 0.8262 82.62%
PPAR gamma + 0.5520 55.20%
Honey bee toxicity - 0.9316 93.16%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity + 0.5200 52.00%
Fish aquatic toxicity + 0.9939 99.39%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1951 P21397 Monoamine oxidase A 97.23% 91.49%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.91% 91.11%
CHEMBL242 Q92731 Estrogen receptor beta 91.52% 98.35%
CHEMBL3401 O75469 Pregnane X receptor 88.86% 94.73%
CHEMBL2581 P07339 Cathepsin D 86.96% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.50% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.47% 96.09%
CHEMBL301 P24941 Cyclin-dependent kinase 2 83.86% 91.23%
CHEMBL3137262 O60341 LSD1/CoREST complex 83.38% 97.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 81.59% 86.33%

Plants that contains it

Top

Cross-Links

Top
PubChem 73213070
NPASS NPC190974